Wikke Walop

1.3k total citations
42 papers, 897 citations indexed

About

Wikke Walop is a scholar working on Epidemiology, Infectious Diseases and General Health Professions. According to data from OpenAlex, Wikke Walop has authored 42 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in General Health Professions. Recurrent topics in Wikke Walop's work include Intramuscular injections and effects (4 papers), Biomedical Text Mining and Ontologies (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Wikke Walop is often cited by papers focused on Intramuscular injections and effects (4 papers), Biomedical Text Mining and Ontologies (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Wikke Walop collaborates with scholars based in Canada, United States and United Kingdom. Wikke Walop's co-authors include C. Ineke Neutel, B Pierquin, Katrin Kohl, Juanita Crook, G. Marinello, Scott A. Halperin, Sandra Jo Hammer, Renald Hennig, Paul T. Heath and Frederick Varricchio and has published in prestigious journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics and Vaccine.

In The Last Decade

Wikke Walop

42 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wikke Walop Canada 18 192 142 130 127 118 42 897
Sarah Forgie Canada 18 283 1.5× 350 2.5× 110 0.8× 78 0.6× 28 0.2× 65 1.0k
Alike W. van der Velden Netherlands 20 428 2.2× 125 0.9× 70 0.5× 60 0.5× 72 0.6× 67 1.7k
Yoko Furuya Japan 12 168 0.9× 137 1.0× 85 0.7× 38 0.3× 35 0.3× 20 612
Sunil Gomber India 18 168 0.9× 203 1.4× 118 0.9× 12 0.1× 59 0.5× 87 1.1k
Kathleen E. Wirth United States 21 322 1.7× 317 2.2× 108 0.8× 19 0.1× 31 0.3× 53 1.1k
Iman Ridda Australia 20 704 3.7× 261 1.8× 79 0.6× 23 0.2× 90 0.8× 36 1.4k
Birgitte Frederiksen Denmark 22 249 1.3× 79 0.6× 149 1.1× 16 0.1× 244 2.1× 34 1.7k
Rachel Isba United Kingdom 14 139 0.7× 55 0.4× 52 0.4× 16 0.1× 122 1.0× 48 955
Fitsum Weldegebreal Ethiopia 19 345 1.8× 299 2.1× 97 0.7× 27 0.2× 38 0.3× 77 916
Farah Yasmin Pakistan 16 215 1.1× 495 3.5× 125 1.0× 13 0.1× 114 1.0× 133 1.4k

Countries citing papers authored by Wikke Walop

Since Specialization
Citations

This map shows the geographic impact of Wikke Walop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wikke Walop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wikke Walop more than expected).

Fields of papers citing papers by Wikke Walop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wikke Walop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wikke Walop. The network helps show where Wikke Walop may publish in the future.

Co-authorship network of co-authors of Wikke Walop

This figure shows the co-authorship network connecting the top 25 collaborators of Wikke Walop. A scholar is included among the top collaborators of Wikke Walop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wikke Walop. Wikke Walop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gidudu, Jane, Katrin Kohl, Scott A. Halperin, et al.. (2008). A local reaction at or near injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 26(52). 6800–6813. 70 indexed citations
2.
3.
Wells, George A., et al.. (2008). Improving Global Monitoring of Vaccine Safety. Drug Safety. 31(5). 389–398. 16 indexed citations
4.
Kohl, Katrin, L. Ball, Jane Gidudu, et al.. (2007). Abscess at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 25(31). 5821–5838. 17 indexed citations
5.
Kohl, Katrin, Wikke Walop, Jane Gidudu, et al.. (2007). Swelling at or near injection site: Case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine. 25(31). 5858–5874. 26 indexed citations
6.
Halperin, Scott A., Katrin Kohl, Jane Gidudu, et al.. (2007). Cellulitis at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 25(31). 5803–5820. 13 indexed citations
7.
Kohl, Katrin, Wikke Walop, Jane Gidudu, et al.. (2007). Induration at or near injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 25(31). 5839–5857. 16 indexed citations
8.
Tolentino, Herman, Michael D. Matters, Wikke Walop, et al.. (2007). A UMLS-based spell checker for natural language processing in vaccine safety. BMC Medical Informatics and Decision Making. 7(1). 3–3. 28 indexed citations
9.
Campbell, Craig, et al.. (2005). Subacute Sclerosing Panencephalitis: Results of the Canadian Paediatric Surveillance Program and review of the literature. BMC Pediatrics. 5(1). 47–47. 38 indexed citations
10.
Clark, M. A., et al.. (2004). A fresh look at an old vaccine: Does BCG have a role in 21st Century Canada?. International Journal of Circumpolar Health. 63(sup2). 230–236. 7 indexed citations
11.
12.
Walop, Wikke, et al.. (2002). Coding of drugs used by respondents of the Canadian Study of Health and Aging.. PubMed. 9(2). 64–8. 6 indexed citations
13.
Neutel, C. Ineke & Wikke Walop. (2000). Comparing two different approaches to measuring drug use within the same survey.. PubMed. 21(4). 150–6. 13 indexed citations
14.
Neutel, C. Ineke & Wikke Walop. (2000). Where is the epidemiology in pharmacovigilance?. Pharmacoepidemiology and Drug Safety. 9(4). 337–340. 5 indexed citations
15.
Beaudet, Marie P., Wikke Walop, & Christel Le Petit. (1997). Characteristics of women on hormone replacement therapy. 2 indexed citations
16.
Jurima‐Romet, Mallé, Joyce A. Goldstein, Michael J. LeBelle, et al.. (1996). CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit population. Pharmacogenetics. 6(4). 329–339. 31 indexed citations
17.
Rowe, Peter C., Wikke Walop, H. Lior, & Alexander MacKenzie. (1991). Haemolytic anaemia after childhoodEscherichia coliO 157.H7 infection: are females at increased risk?. Epidemiology and Infection. 106(3). 523–530. 19 indexed citations
18.
Mazeron, J.J., Juanita Crook, G. Marinello, Wikke Walop, & B Pierquin. (1990). Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation. International Journal of Radiation Oncology*Biology*Physics. 19(2). 281–285. 60 indexed citations
19.
Walop, Wikke, Michel Chrétien, Neil Colman, et al.. (1990). The use of biomarkers in the prediction of survival in patients with pulmonary carcinoma. Cancer. 65(9). 2033–2046. 23 indexed citations
20.
Mazeron, J.J., Juanita Crook, G. Marinello, et al.. (1990). Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue. International Journal of Radiation Oncology*Biology*Physics. 19(6). 1369–1376. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Forgie Breakdown of academic impact, for papers by Alike W. van der Velden Breakdown of academic impact, for papers by Yoko Furuya Breakdown of academic impact, for papers by Sunil Gomber Breakdown of academic impact, for papers by Kathleen E. Wirth Breakdown of academic impact, for papers by Iman Ridda Breakdown of academic impact, for papers by Birgitte Frederiksen Breakdown of academic impact, for papers by Rachel Isba Breakdown of academic impact, for papers by Fitsum Weldegebreal Breakdown of academic impact, for papers by Farah Yasmin
Rankless by CCL
2026